<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30771">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02706119</url>
  </required_header>
  <id_info>
    <org_study_id>FPS-INSUPAR-2015-01</org_study_id>
    <nct_id>NCT02706119</nct_id>
  </id_info>
  <brief_title>Insulin in Total Parenteral Nutrition</brief_title>
  <acronym>INSUPAR</acronym>
  <official_title>Subcutaneous Versus Intravenous Basal Insulin in Non-critical Hospitalized Diabetic Patients That Receive Total Parenteral Nutrition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Pública Andaluza Progreso y Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Analyze the level of metabolic control achieved with a routine of regular insulin in the
      parenteral nutrition (PN) reservoir in addition to subcutaneous glargine insulin, versus
      only regular insulin in the PN reservoir.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A pattern of basal insulin (using subcutaneous insulin glargine and regulating the stock as
      prandial), plus regular subcutaneous insulin as rescue, applied to total parenteral
      nutrition (TPN) should be as effective (glycemic control, variability) and safe
      (hypoglycemia) as the usual (regular insulin inside the TPN reservoir and subcutaneous
      insulin as rescue) in patients with type 2 diabetes critics.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Basal blood glucose value before starting TPN</measure>
    <time_frame>Before starting total parenteral nutrition</time_frame>
    <description>Basal glucose value before starting TPN (in mg/dL).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Periodical blood glucose</measure>
    <time_frame>Every 6h during 15 days of treatment</time_frame>
    <description>All blood glucose values (in mg/dL) every 6 hours during 15 days of TPN infusion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Variation of average blood glucose compared with total dose of insulin</measure>
    <time_frame>In days 1, 5 and 15 of treatment</time_frame>
    <description>Variation of average glucose (in mg/dL) compared with total dose of insulin (in mL), in days 1, 5 and 15 of treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of hypoglycaemia</measure>
    <time_frame>During TPN treatment up to 15 days</time_frame>
    <description>Number of symptomatic and asymptomatic hypoglycaemia with blood glucose below 70 mg/dL during TPN treatment up to 15 days.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of severe hypoglycaemia</measure>
    <time_frame>During TPN treatment up to 15 days</time_frame>
    <description>Number of symptomatic and asymptomatic hypoglycaemia with blood glucose below 40 mg/dL during TPN treatment up to 15 days.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hypoglycemia blood glucose values</measure>
    <time_frame>Through study completion, an average of 15 days.</time_frame>
    <description>If the patient refers typical symptoms of hypoglycemia, a measure of blood glucose (in mg/mL) is immediately taken to check the level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hypoglycemia symptoms</measure>
    <time_frame>Through study completion, an average of 15 days.</time_frame>
    <description>If blood glucose &lt;70 mg / dL, it is recorded whether or not the patient has symptoms consistent with hypoglycemia and how the episode terminates</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Standard deviation of blood glucose</measure>
    <time_frame>At day 15 of treatment</time_frame>
    <description>Standard deviation of blood glucose (SD): Expressed in milligrams per deciliter (in mg/dL).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood glucose coefficient of variation (CV)</measure>
    <time_frame>At day 15 of treatment</time_frame>
    <description>Coefficient of variation (CV): Expressed as a percentage (%). The ratio of the standard deviation of the blood glucoses values (in mg/dL) and the average blood glucose (in mg/dL), multiplied by 100.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Infections related with catheter used in parenteral nutrition</measure>
    <time_frame>At day 15 of treatment</time_frame>
    <description>Investigator asses the occurrence of infectious complications in parenteral nutrition catheter. For the evaluation of the infections, temperature is collected daily and patient will perform a blood test weekly. It will be suspected infectious complication for any sudden onset of fever (usually &quot;peaks&quot;), with no other apparent source of infection.</description>
  </other_outcome>
  <other_outcome>
    <measure>Hypertriglyceridemia</measure>
    <time_frame>Every 6h during 15 days of treatment.</time_frame>
    <description>A determination above this value will be considered a complication: Hypertriglyceridemia ≥500 mg/dL</description>
  </other_outcome>
  <other_outcome>
    <measure>Hypernatremia</measure>
    <time_frame>Every 6h during 15 days of treatment.</time_frame>
    <description>A determination above this value will be considered a complication: Hypernatremia &gt;150 mEq/L</description>
  </other_outcome>
  <other_outcome>
    <measure>Hyponatremia</measure>
    <time_frame>Every 6h during 15 days of treatment.</time_frame>
    <description>A determination below this value will be considered a complication: Hyponatremia &lt;135 mEq/L</description>
  </other_outcome>
  <other_outcome>
    <measure>Hypokalemia</measure>
    <time_frame>Every 6h during 15 days of treatment.</time_frame>
    <description>A determination below this value will be considered a complication: Hypokalemia &lt;3 mEq/L</description>
  </other_outcome>
  <other_outcome>
    <measure>Hypomagnesemia</measure>
    <time_frame>Every 6h during 15 days of treatment.</time_frame>
    <description>A determination below this value will be considered a complication: Hypomagnesemia &lt;1.2 mg/dL</description>
  </other_outcome>
  <other_outcome>
    <measure>Hypophosphatemia</measure>
    <time_frame>Every 6h during 15 days of treatment.</time_frame>
    <description>A determination below this value will be considered a complication: Hypophosphatemia &lt;2 mg/dL</description>
  </other_outcome>
  <other_outcome>
    <measure>Hyperchloremia</measure>
    <time_frame>Every 6h during 15 days of treatment.</time_frame>
    <description>A determination above this value will be considered a complication: Hyperchloremia &gt;120 mEq/L</description>
  </other_outcome>
  <other_outcome>
    <measure>Hypocalcemia corrected calcium</measure>
    <time_frame>Every 6h during 15 days of treatment.</time_frame>
    <description>A determination below this value will be considered a complication: Hypocalcemia corrected calcium &lt;8 mg/dL</description>
  </other_outcome>
  <other_outcome>
    <measure>Alteration of liver function markers</measure>
    <time_frame>At day 7 and 15 of treatment</time_frame>
    <description>Alteration of liver function markers is defined as an elevation twice higher than normal limits, according to each laboratory, of two of some of the following parameters (when previously normal): GGT, GOT, GPT, FA or total bilirubin, at least 7 days after initiating TPN.</description>
  </other_outcome>
  <other_outcome>
    <measure>Adverse events</measure>
    <time_frame>At day 15 of treatment</time_frame>
    <description>All adverse events (AEs) are recorded in the case report data since the moment when the patient signs the informed consent. These events will be defined following the organ classification database of MedDRA system.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Glargine insulin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose glargine insulin (basal component) + regular insulin within total parenteral nutrition (TPN) reservoir (prandial component). 50% of the total calculated dose of insulin is administered subcutaneously as single dose subcutaneous glargine insulin; remaining 50% of the total calculated dose of insulin is administered as regular insulin in the TPN reservoir. Interventions used: Intravenous glargine insulin, and regular insulin added to TPN bag</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regular insulin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular insulin added to TPN bag (basal + prandial component). The calculated total dose of insulin is administered as regular insulin in the TPN reservoir. Interventions used: Regular insulin added to TPN bag</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Subcutaneous glargine insulin</intervention_name>
    <description>Glargine insuline is an insulin analogue which has a prolonged duration of action. Insulin glargine is obtained by recombinant DNA technology in Escherichia coli.</description>
    <arm_group_label>Glargine insulin</arm_group_label>
    <other_name>ATC code A10AE0</other_name>
    <other_name>Lantus®</other_name>
    <other_name>Abasaglar®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Regular insulin added to TPN bag</intervention_name>
    <description>Regular insulin is human insulin produced in Saccharomyces cerevisiae by recombinant DNA technology.</description>
    <arm_group_label>Glargine insulin</arm_group_label>
    <arm_group_label>Regular insulin</arm_group_label>
    <other_name>ATC code A10AB01</other_name>
    <other_name>Actrapid®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (&gt;18 years)

          -  Previously diagnosed with diabetes mellitus.

          -  Hospitalized but without intensive cares.

          -  Have indication of total parenteral nutritional support (TPN, meaning the covering
             over 70% of the estimated daily requirements intravenously) for a minimum of 5 days.

          -  Signature of informed consent.

        Exclusion Criteria:

          -  Diabetes mellitus type 1, diabetes secondary to total pancreatectomy.

          -  Patients with intensive cares.

          -  Patients who have been prescribed TPN in intensive cares unity more than 48 hours
             before admission to hospitalization.

          -  Intradialytic parenteral nutrition.

          -  Patients under 18 or pregnant women.

          -  Patients with renal insufficiency stage 3 B (glomerular filtration rate &lt; 45 mL /
             min).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabriel Olveira Fuster, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Regional Universitario de Málaga</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gabriel Olveira Fuster, PhD</last_name>
    <phone>951290343</phone>
    <email>gabrielm.olveira.sspa@juntadeandalucia.es; gabrielolveiracasa@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>María del Mar Benjumea Vargas</last_name>
    <phone>955040450</phone>
    <email>gestionensayosclinicos.fps@juntadeandalucia.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Arquitecto Marcide-Naval</name>
      <address>
        <city>Ferrol</city>
        <state>A coruña</state>
        <zip>15405</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Diego Bellido Guerrero, PhD</last_name>
      <phone>981454513; 981337908</phone>
      <email>diego_bellido@arrakis.es; diegobellido@gmail.com; diego.bellido@udc.es</email>
    </contact>
    <investigator>
      <last_name>Diego Bellido Guerrero, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Tejera Pérez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paula Andújar Plata</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Cabueñes</name>
      <address>
        <city>Gijón</city>
        <state>Asturias</state>
        <zip>33394</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laura Manjón Miguélez, MD</last_name>
      <phone>985185000</phone>
      <email>lauramanjonmiguelez@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Laura Manjón Miguélez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Mérida</name>
      <address>
        <city>Mérida</city>
        <state>Badajoz</state>
        <zip>06800</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan Parra Barona, MD</last_name>
      <phone>924381000</phone>
      <phone_ext>81048</phone_ext>
      <email>juanparrabarona@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Juan Parra Barona, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rocío Burguillos García</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Álvaro Sillero Sánchez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ignacio Rasero Hernández</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Victoria Collado Gómez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Consolación Barbet García</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Son Llátzer</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Baleares</state>
        <zip>07198</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Josefina Olivares Alcolea, MD</last_name>
      <phone>871202000</phone>
      <email>jolivares@hsll.es</email>
    </contact>
    <investigator>
      <last_name>Josefina Olivares Alcolea, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Mancha Centro</name>
      <address>
        <city>Alcázar de San Juan</city>
        <state>Ciudad Real</state>
        <zip>13600</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Álvaro García-Manzanares Vázquez de Gredos, PhD</last_name>
      <phone>926580500</phone>
      <phone_ext>80316</phone_ext>
      <email>agmanzanares2010@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Álvaro García-Manzanares Vázquez de Gredos, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>María del Carmen Conde García</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Principe de Asturias</name>
      <address>
        <city>Alcalá de Henares</city>
        <state>Madrid</state>
        <zip>28805</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Álvarez Hernández, PhD</last_name>
      <phone>918878100</phone>
      <phone_ext>4028</phone_ext>
      <email>julia.alvarez@movistar.es</email>
    </contact>
    <investigator>
      <last_name>Julia Álvarez Hernández, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Águeda Muñoz Jiménez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Noelia Peláez Torres</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Fuenlabrada</name>
      <address>
        <city>Fuenlabrada</city>
        <state>Madrid</state>
        <zip>28942</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emilia Cancer Minchot</last_name>
      <phone>916006186</phone>
      <email>emilia.cancer@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Emilia Cancer Minchot</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alicia Sánchez Borreguero</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Severo Ochoa</name>
      <address>
        <city>Leganés</city>
        <state>Madrid</state>
        <zip>28911</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jorge Daniel Martín González, MD</last_name>
      <phone>914818453; 916898904</phone>
      <email>jdmartinglez@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jorge Daniel Martín González, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Blanca Oliván Palacios, PhD</last_name>
      <phone>911916000</phone>
      <phone_ext>7212</phone_ext>
      <email>blanca_olivan@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Blanca Oliván Palacios, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rocío Campos del Portillo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginia Osés Zárate</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nerea Gil Fernández</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Beatriz Pérez Ruiz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Mateos Moreno</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alberto Sánchez Cámara</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marta Araujo Castro</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Virgen de la Arrixaca</name>
      <address>
        <city>El Palmar</city>
        <state>Murcia</state>
        <zip>30150</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mercedes Ferrer Gómez, MD</last_name>
      <phone>968369570</phone>
      <email>tofly16@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mercedes Ferrer Gómez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>María Victoria García Zafra</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ana Zugasti Murillo, MD</last_name>
      <phone>848422519</phone>
      <email>azugas@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Ana Zugasti Murillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Estrella Petrina Jáuregui</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Albacete</name>
      <address>
        <city>Albacete</city>
        <zip>02008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francisco Botella Romero, PhD</last_name>
      <phone>967597141</phone>
      <email>fbotellar@sescam.jccm.es</email>
    </contact>
    <investigator>
      <last_name>Francisco Botella Romero, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rosa Pilar Quílez Toboso</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Alicante</name>
      <address>
        <city>Alicante</city>
        <zip>03010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ángel Luis Abad González, MD</last_name>
      <phone>965913783; 965913779</phone>
      <email>angeluis1024@ono.com</email>
    </contact>
    <investigator>
      <last_name>Ángel Luis Abad González, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Víctor Luis González Sánchez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>José Javier Campuzano Jara</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Infanta Cristina</name>
      <address>
        <city>Badajoz</city>
        <zip>06080</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luis Miguel Luengo Perez, PhD</last_name>
      <phone>924218081; 924218110</phone>
      <email>luismiluengo@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Luis Miguel Luengo Perez, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>María José Carrera Santaliestra, MD</last_name>
      <phone>932483902; 932483254</phone>
      <email>jcarrera@pardesalutmar.cat; 92734@parcdesalutmar.cat</email>
    </contact>
    <investigator>
      <last_name>María José Carrera Santaliestra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xavier Mateu de Antonio</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gemma Llauradó Cabot</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisenda Climent Biescas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Bellvitge</name>
      <address>
        <city>Barcelona</city>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>María Nuria Virgili Casas, PhD</last_name>
      <phone>932607529</phone>
      <email>mvirgili@bellvitgehospital.cat</email>
    </contact>
    <investigator>
      <last_name>María Nuria Virgili Casas, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rafael López Urdiales</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paula García Sancho de la Jordana</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luís San Martín Tresols</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>María Badía Tahull</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisabet Leiva Badosa</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Sant Joan Despi Moisès Broggi (Consorci Sanitari Integral)</name>
      <address>
        <city>Barcelona</city>
        <zip>08970</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sara Torrejón Jaramillo, MD</last_name>
      <phone>935531200</phone>
      <phone_ext>8747</phone_ext>
      <email>sara.torrejon@sanitatintegral.org</email>
    </contact>
    <investigator>
      <last_name>Sara Torrejón Jaramillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lluís Vila Ballester</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irela López Cobo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gemma Francisco Expósito</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raquel Bornés Cerrato</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofía</name>
      <address>
        <city>Córdoba</city>
        <zip>14006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>María José Molina Puerta, PhD</last_name>
      <phone>957010174</phone>
      <email>cmmerinomjmolina@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>María José Molina Puerta, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Inmaculada Prior Sánchez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Guadalajara</name>
      <address>
        <city>Guadalajara</city>
        <zip>19002</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sandra Herranz Antolín, MD</last_name>
      <phone>949209200</phone>
      <phone_ext>69263</phone_ext>
      <email>herranzantolin@yahoo.es</email>
    </contact>
    <investigator>
      <last_name>Sandra Herranz Antolín, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Visitación Álvarez de Frutos</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Jaén</name>
      <address>
        <city>Jaén</city>
        <zip>23008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carmen Arraiza Irigoyen, MD</last_name>
      <phone>953008580; 953008169</phone>
      <email>karmarrai@yahoo.es; mc.arraiza.sspa@juntadeandalucia.es</email>
    </contact>
    <investigator>
      <last_name>Carmen Arraiza Irigoyen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carmen Tenorio Jiménez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complejo Asistencial Universitario de León</name>
      <address>
        <city>León</city>
        <zip>24008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alfonso José Vidal Casariego, PhD</last_name>
      <phone>987237400</phone>
      <phone_ext>43044</phone_ext>
      <email>avcyo@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Alfonso José Vidal Casariego, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>María Dolores Ballesteros Pomar</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana María Urioste Fondo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rocío Villar Taibo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Concepción Guindel Jiménez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Irene Bretón Lesmes, MD</last_name>
      <phone>915868541</phone>
      <email>irene.breton@salud.madrid.org; irenebreton@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Irene Bretón Lesmes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>María Cristina de la Cuerda Compes</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Camblor Álvarez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundación Jiménez Díaz</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carmen Aragón Valera, MD</last_name>
      <phone>915504800</phone>
      <phone_ext>2251</phone_ext>
      <email>caragonva@fjd.es</email>
    </contact>
    <investigator>
      <last_name>Carmen Aragón Valera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olga Sánchez-Vilar Burdiel</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elena López-Mezquita Torres</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Natalia Pérez Ferré, PhD</last_name>
      <phone>913303281; 913303117</phone>
      <email>npferre@salud.madrid.org; nataliaferre79@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Natalia Pérez Ferré</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pilar Matía Martín</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Ánguel Rubio Herrera</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Regional Universitario de Málaga</name>
      <address>
        <city>Málaga</city>
        <zip>29009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gabriel Olveira Fuster, PhD</last_name>
      <phone>951290343</phone>
      <email>gabrielm.olveira.sspa@juntadeandalucia.es; gabrielolveiracasa@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>María José Tapia Guerrero, PhD</last_name>
      <phone>951290343</phone>
      <email>mjtapiague@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Gabriel Olveira Fuster, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>María José Tapia Guerrero, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>José Albuin Fernández</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Victoria</name>
      <address>
        <city>Málaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Manuel García Almeida, PhD</last_name>
      <phone>951032242</phone>
      <email>jgarciaalmeida@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>José Manuel García Almeida, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Luis Villalobos Gámez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>María Molina Vega</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Luís Pereira Cunill, PhD</last_name>
      <phone>955012026</phone>
      <email>jpereira@cica.es</email>
    </contact>
    <investigator>
      <last_name>José Luís Pereira Cunill, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pilar Serrano Aguayo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Nuestra Señora de la Candelaria</name>
      <address>
        <city>Tenerife</city>
        <zip>38010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>María Araceli García Nuñez, MD</last_name>
      <phone>922602972</phone>
      <email>mgnendocrino@gmail.com</email>
    </contact>
    <investigator>
      <last_name>María Araceli García Nuñez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>José Pablo Suárez Llanos</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francisca Pereyra-García Castro</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario y Politécnico La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katherine García Malpartida, MD</last_name>
      <phone>961245554; 961246202</phone>
      <email>kathe.garciamalpartida@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Katherine García Malpartida, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Francisco Merino Torres</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>María Argente Pla</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Beatriz Alicia León de Zayas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matilde Rubio Almanza</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alia María García Castells</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silvia Martín Sanchís</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Micó García</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <zip>47003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan José López Gómez</last_name>
      <phone>983420000</phone>
      <phone_ext>86660</phone_ext>
      <email>jjlopez161282@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Daniel Antonio de Luis Román</last_name>
      <phone>983420000</phone>
      <phone_ext>86660</phone_ext>
      <email>dadluis@yahoo.es</email>
    </contact_backup>
    <investigator>
      <last_name>Juan José López Gómez</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Antonio de Luis Román</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilia Gómez Hoyos</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Beatriz Torres Torres</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julia Ocón Bretón, MD</last_name>
      <phone>976556400</phone>
      <phone_ext>162832</phone_ext>
      <email>mjocon@salud.aragon.es</email>
    </contact>
    <investigator>
      <last_name>Julia Ocón Bretón, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julia Campos Fernández</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Agudo Tabuenca</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alejandro Sanz París, PhD</last_name>
      <phone>976765500</phone>
      <phone_ext>1425</phone_ext>
      <email>sanzparisalejandro@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Alejandro Sanz París, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>April 3, 2017</lastchanged_date>
  <firstreceived_date>February 16, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>total parenteral nutrition</keyword>
  <keyword>glargine insulin</keyword>
  <keyword>insulin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin Glargine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
